8-K ·Filed Oct 13, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor Niki BioSolutions' capital-raising progress, as the CFO's deferred salary and salary increase are tied to $3M and $5M cumulative capital investments, respectively.
Price Chart
Loading chart...
Executive Summary
Niki BioSolutions appointed Thomas Freeburg as CFO effective September 1, 2026, with a two-year employment agreement. The filing is a routine executive appointment with standard compensation terms and no red flags such as unexpected departure or resignation.
Key Facts
- Thomas Freeburg appointed CFO effective September 1, 2026
- Base salary of $250,000, with $25,000 deferred until $3M in capital raised; increases to $275,000 upon $5M in capital raised
- Eligible for annual bonus up to 50% of base salary
- Granted 50,000 stock options at $8.83 per share with milestone and time-based vesting
- Two-year initial term with automatic one-year renewals
Financial Impact
Standard CFO compensation package; no material financial impact disclosed
Risk Factors
- No material risks identified from this routine appointment
Investment Themes
Industrials & Manufacturing
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-109016 |
| Document: ea0308307-8k_niki.htm | 0001213900-26-109016 |
| Document: 0001213900-26-109016-index-headers.html | 0001213900-26-109016 |
| Document: 0001213900-26-109016-index.html | 0001213900-26-109016 |
| Document: 0001213900-26-109016.txt | 0001213900-26-109016 |
10 reports for APM
67% Hit rate @ T+1 Went positive at some point 2 of 3 best @ T+60▲ +7.34%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 8-K | — | awaiting T+1 | — | — |
Oct 9, 2026 18d ago | 8-K | — | awaiting T+1 | — | — |
Oct 9, 2026 18d ago | 424B5 | — | awaiting T+1 | — | — |
Jul 20, 2026 14w ago | 8-K | $8.83 $9.54 | ▲ +8.04% | ▲ +7.21% | — |
Jul 16, 2026 14w ago | Press Release | $0.6924 $0.7000 | ▲ +1.10% | ▲ +2.09% | — |
Jun 10, 2026 19w ago | 6-K | $0.9038 $0.8900 | ▼ −1.53% | ▼ −3.23% | — |
Jun 4, 2026 20w ago | EFFECT | $1.09 $1.01 | ▼ −7.34% | ▼ −4.74% | — |
May 14, 2026 23w ago | 6-K | $0.8230 $0.8570 | ▼ −4.13% | ▼ −4.19% | — |
Mar 27, 2026 30w ago | 20-F | $0.8380 $0.7960 | ▲ +5.01% | ▲ +7.90% | — |
Mar 6, 2026 33w ago | Press Release | $0.8000 $0.7930 | ▲ +0.88% | ▲ +0.69% | — |
Showing 10 of 10
US Market Status
Market Closed — Opens in 8h 22m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers